Ribo-Zero Plus Microbiome rRNA Depletion Kit

Expand the discovery power of metatranscriptomics with the Ribo-ZeroTM Plus Microbiome Depletion Kit. This kit enables rapid and efficient removal of human, mouse, rat and bacterial rRNA for high-throughput microbial transcriptomics applications.

Metatranscriptomics attempts to describe the transcriptome (the total messenger RNA expressed in a genome) of a set of organisms from a sample. The kit offered by Illumina consists of reagents to remove human and bacterial ribosomal RNA (23S, 5S and 16S) from the sample and to prepare libraries from RNA. The reagents that perform this depletion consist of 1092 specific capture probes.


This application is more focused for research centers, which are interested in the study of the expression of these genes and the search for metabolic pathways.

Imagen1 4

Other features:

  • Minimum 50 million reads/sample (only suitable for NexSeq or NovaSeq platforms).
  • Analysis software included.
  • 96-reaction format

Area:

Metatranscriptomics, Microbiology

Brand:

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SureSelect Cancer CGP Assay

Targeted-enrichment NGS pan-cancer panel for comprehensive genomic profiling (CGP) of solid tumours. Designed to detect somatic variants at DNA level (SNVs, indels, CNVs, translocations) and RNA level (gene fusions), as well as to assess complex immuno-oncology biomarkers such as tumour mutational burden (TMB), microsatellite instability (MSI) and homologous recombination deficiency (HRD). Detailed Description Operating principle…
Agilent
Next Generation Sequencing (NGS)

SeqOne HRD Solution con Agilent SureSelect CD HRR17 Panel

HRD analysis solution combining low-coverage whole-genome sequencing (shallow/low-pass WGS) and a targeted gene panel to detect genomic instability, BRCA1/2 alterations and other genes related to homologous recombination. It is designed for laboratories wishing to implement HRD testing in-house with an automated, efficient and clinically validated workflow. Detailed Description SeqOne’s HRD solution combines shallow WGS and…
Agilent
Next Generation Sequencing (NGS)

OncoSELECT®

Comprehensive targeted liquid biopsy assay designed to support decision-making in oncology through the analysis of 74 clinically relevant genes. The solution encompasses everything from library preparation reagents to bioinformatics analysis, clinical interpretation and the generation of detailed reports. 3.- Detailed Description Operating principle OncoSELECT® is an advanced liquid biopsy panel based on circulating cell-free DNA…
OncoDNA
Next Generation Sequencing (NGS)

Agilent SureSelect Human All Exon V8.

High-performance exome for the enrichment of human coding regions, with updated coverage of RefSeq, CCDS and GENCODE, including the TERT promoter and difficult-to-capture exons. 3.- Detailed Description Operating principle SureSelect Human All Exon V8 is based on NGS library preparation and capture enrichment of target regions of the human exome. The workflow is compatible with…
Agilent
Next Generation Sequencing (NGS)